Heron Therapeutics
HRTX
HRTX
176 hedge funds and large institutions have $1.74B invested in Heron Therapeutics in 2019 Q2 according to their latest regulatory filings, with 24 funds opening new positions, 77 increasing their positions, 50 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
23% less capital invested
Capital invested by funds: $2.27B → $1.74B (-$521M)
44% less first-time investments, than exits
New positions opened: 24 | Existing positions closed: 43
73% less funds holding in top 10
Funds holding in top 10: 11 → 3 (-8)
Holders
176
Holding in Top 10
3
Calls
$7.2M
Puts
$6.8M
Top Buyers
| 1 | +$23M | |
| 2 | +$18.6M | |
| 3 | +$15.4M | |
| 4 |
BM
Bridger Management
New York
|
+$15.1M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$13.9M |
Top Sellers
| 1 | -$36.7M | |
| 2 | -$26.1M | |
| 3 | -$17.7M | |
| 4 |
SIM
Stelliam Investment Management
New York
|
-$15.6M |
| 5 |
KAM
Kavi Asset Management
New York
|
-$14.9M |